{"filings":[{"id":93633,"accession_number":"0001493152-26-021493","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2026-05-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore Q1 revenue $9.6M (+43% YoY); reaffirms ~30% FY2026 growth guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $9.6M, record quarterly revenue, up 43% from $6.7M Q1 2025.","GAAP net loss $5.3M ($0.59 per share); includes $1.9M leadership transition expenses.","Adjusted EBITDA net loss improved 24% YoY to $2.3M from $3.1M.","VA prescription gammaCore revenue grew 26% YoY; Quell Fibromyalgia quarterly sales >$1M.","Michael Fox appointed COO in April 2026; Truvaga launched in UK in January 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.59,"consensus_revenue_estimate":null,"consensus_revenue_actual":9584000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":105426,"accession_number":"0001493152-26-011620","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2026-03-19T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore FY2025 revenue $32M (+27% YoY); CEO Goldberger to retire","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $32.0M, up 27% YoY; US Rx +25%, general wellness +97%.","GAAP net loss $14.0M ($1.65/share) vs $11.9M loss prior year.","Adjusted EBITDA net loss $8.7M vs $9.0M; cash $11.6M at Dec 2025.","FY2026 guidance: ~30% annual revenue growth over 2025.","CEO Dan Goldberger retiring Apr 1; CFO Lev interim President; Michael Fox named COO."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":105425,"accession_number":"0001493152-26-002847","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2026-01-20T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"electroCore prelim FY2025 rev $31.8-32.0M (+26%); Q4 rev ~$9.0-9.2M (+30%)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Preliminary FY2025 revenue $31.8–$32.0M, ~26% growth over FY2024 of $25.2M.","Q4 2025 revenue $9.0–$9.2M, ~30% growth over Q4 2024.","Cash, cash equivalents, and marketable securities ~$11.6M at Dec 31, 2025 (vs $13.2M Sep 30, 2025).","Company will provide detailed operational and financial update in March 2026 earnings call."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.65,"consensus_revenue_estimate":null,"consensus_revenue_actual":32032000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121706,"accession_number":"0001493152-25-020878","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore Q3 net sales $8.7M up 33% YoY; raises FY2025 revenue guidance to $31.5-$32.5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $8.7M, 33% increase YoY; YTD net sales $22.8M, up 26% vs first nine months of 2024.","Net loss $3.4M ($0.40 per share) vs $2.5M loss in Q3 2024; adjusted EBITDA net loss $2.0M vs $2.1M.","FY2025 revenue guidance raised to $31.5-$32.5M; expects first quarter of positive adjusted EBITDA in H2 2026.","Total cash $13.2M at Sep 30, 2025, up from $12.2M at Dec 31, 2024.","Prescription devices sales $6.81M (+19% YoY); health & wellness $1.88M (+121% YoY)."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.31,"consensus_revenue_estimate":null,"consensus_revenue_actual":22789000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121705,"accession_number":"0001493152-25-016869","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2025-10-03T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"electroCore issues 360,737 shares at $5.145 to settle legal fee obligations","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["360,737 shares issued at $5.145 per share to settle outstanding legal fees owed to investors.","No cash proceeds received; shares issued directly in satisfaction of debt.","Private placement closed October 2, 2025; resale registration to be filed within 90 days.","Company agreed to indemnify purchasers for certain liabilities under Securities Act."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138386,"accession_number":"0001641172-25-026318","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2025-09-03T23:59:59+00:00","items":["5.02","5.07","7.01","9.01"],"status":"ready","headline":"electroCore appoints Microsoft healthcare head Elena Bonfiglioli to board; declassification fails","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Elena Bonfiglioli, Microsoft Global Business Leader Healthcare, appointed to board effective Sept 2, 2025.","Dr. Thomas Errico appointed Chairman, succeeding Peter Cuneo who retired.","Annual meeting: Board declassification proposal failed; 94.6% of votes cast in favor but only 14.05% of outstanding shares voted.","Three Class I directors re-elected: Daniel Goldberger, Julie Goldstein, Patricia Wilber.","Ratification of CBIZ CPAs as auditor and advisory say-on-pay approved at annual meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138385,"accession_number":"0001641172-25-022427","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2025-08-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore Q2 2025 revenue up 20% to $7.4M; net loss widens to $3.7M; raises $7.2M debt","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $7.4M in Q2 2025, up 20% YoY ($6.1M); YTD sales $14.1M up 22%.","GAAP net loss $3.7M ($0.44 loss per share) vs $2.7M ($0.38 loss) in Q2 2024.","Cash and securities $7.4M at June 30; raised $7.2M via term debt on Aug 4, 2025.","Full year 2025 revenue guidance ~$30.0M; net cash usage remainder of year $3.9-4.4M.","VA Rx gammaCore sales up 13% to $5.2M; Truvaga up 74% to $994K; Quell VA added $114K."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.91,"consensus_revenue_estimate":null,"consensus_revenue_actual":14100000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138384,"accession_number":"0001641172-25-019883","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K/A","filed_at":"2025-07-16T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"electroCore amends 8-K: NeuroMetrix acquisition deemed not significant; no financials required","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Filed 8-K/A on July 16, 2025 to amend the May 2, 2025 original report on the NeuroMetrix merger.","Company determined, after SEC staff consultation, that NURO is not a 'significant subsidiary' under Reg S-X.","As a result, audited and pro forma financial statements for NURO are not required under Item 9.01.","Merger closed on May 1, 2025 with NURO surviving as a wholly owned subsidiary of electroCore."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155832,"accession_number":"0001641172-25-009039","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2025-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore Q1 revenue up 23% to $6.7M; net loss $3.9M; guides FY25 revenue ~$30M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 2025 revenue $6.7M (+23% YoY); GAAP net loss $3.9M ($0.47 loss per share).","Adjusted EBITDA net loss $3.1M vs $3.2M in Q1 2024.","Cash & equivalents $8.0M at Mar 31, 2025 (down from $12.2M at Dec 2024).","FY 2025 revenue guidance ~$30.0M; expected net cash use $3.8-$4.3M for next 3 quarters.","Closed NeuroMetrix acquisition; Quell contributed ~$170k in Q1 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.47,"consensus_revenue_estimate":null,"consensus_revenue_actual":6719000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155831,"accession_number":"0001641172-25-008177","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2025-05-02T23:59:59+00:00","items":["2.01","7.01","8.01","9.01"],"status":"ready","headline":"electroCore completes acquisition of NeuroMetrix; $4.49/share plus CVRs","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Cash consideration of $4.49 per NURO share; each share also gets one CVR tied to Quell sales milestones.","CVR payments include 8% of Quell Net Sales up to $500K in first year, 6% in second year, plus DPNCheck proceeds.","electroCore gains Quell Fibromyalgia Solution, expects to leverage VA Hospital System distribution channel.","NURO shares to be de-listed from Nasdaq Capital Market before trading on May 2, 2025.","Transaction approved by NURO stockholders on March 21, 2025; closed May 1, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155830,"accession_number":"0001193805-25-000419","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2025-04-03T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"electroCore replaces auditor Marcum LLP with CBIZ CPAs after attest business acquisition","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Marcum LLP resigned as independent registered public accounting firm on April 1, 2025; CBIZ CPAs P.C. engaged for FY 2025.","Change follows CBIZ CPAs' acquisition of Marcum's attest business effective November 1, 2024.","No disagreements with Marcum on accounting principles; prior material weakness in internal controls (Sept 30, 2023) has been remediated.","Marcum furnished a letter to the SEC (Exhibit 16.1) agreeing with the 8-K statements."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":174299,"accession_number":"0001213900-25-023217","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2025-03-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore FY2024 revenue $25.2M (+57% YoY); net loss narrows to $11.9M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Full year 2024 net sales of $25.2M, up 57% from $16.0M in 2023, driven by 85% growth in VA channel and 174% increase in Truvaga.","GAAP net loss $11.9M ($1.59 EPS) vs $18.8M ($3.42 EPS) in 2023; Adjusted EBITDA net loss $9.0M vs $15.4M.","Gross margin improved to 85% from 83%; cash and securities $12.2M at Dec 31, 2024 vs $10.6M a year ago.","Operating expenses $33.6M, up slightly from $32.5M; R&D down to $2.4M from $5.3M on reduced Truvaga Plus development.","Company cites pending acquisition of NeuroMetrix as part of inorganic expansion strategy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":174298,"accession_number":"0001193805-25-000253","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2025-02-28T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Charles S. Theofilos resigns from electroCore Board; Board size reduced to seven","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Charles S. Theofilos, M.D. resigned as Class III director and from Compensation and Nominating/Governance Committees effective Feb 24, 2025.","Board decreased its size from eight to seven members effective Feb 28, 2025.","Resignation effective immediately; no reason disclosed in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":174297,"accession_number":"0001193805-25-000048","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2025-01-17T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"electroCore reports preliminary Q4 2024 revenue of $7.07M and FY2024 revenue of $25.2M","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Preliminary net revenue for Q4 2024: $7.07 million.","Preliminary net revenue for FY2024: $25.2 million.","Cash, restricted cash, cash equivalents, and marketable securities as of Dec 31, 2024: $12.2 million.","Results are unaudited and provided for upcoming investor presentations."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.59,"consensus_revenue_estimate":null,"consensus_revenue_actual":25182000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":191249,"accession_number":"0001193805-24-001481","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2024-12-17T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"electroCore to acquire NeuroMetrix in cash+CVR merger valuing NURO at net cash plus milestones","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["NURO shareholders receive pro rata share of net cash (min $8M condition) and one CVR per share.","CVR pays up to ~$500K/yr based on 8% Quell Net Sales (Yr1) and 6% (Yr2), plus DPNCheck proceeds.","Voting agreements cover ~6.3% of NURO shares; NURO pays $500K termination fee in certain cases.","Closing requires NURO stockholder approval, FY2024 10-K filing, net cash >$8M, and no material adverse effect.","Deal must close by June 15, 2025; either party can terminate if not consummated by then."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":191248,"accession_number":"0001193805-24-001420","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2024-11-29T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"electroCore enters $20M ATM offering with H.C. Wainwright","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["ATM agreement allows sale of up to $20M of common stock at market prices.","3.0% commission to Wainwright; net proceeds for sales/marketing and working capital.","Shares sold via Nasdaq at-the-market; no obligation to sell any shares.","Offering under existing effective S-3 registration statement; prospectus supplement filed.","Agreement date November 29, 2024; can be terminated by either party at any time."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":191247,"accession_number":"0001213900-24-097484","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2024-11-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore Q3 revenue $6.6M, +45% YoY; net loss narrows to $2.5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Record Q3 revenue of $6.6M, up 45% from $4.5M in Q3 2023; Rx gammaCore VA/DoD sales +75% to $4.8M.","GAAP net loss improved 38% to $2.5M from $4.0M; diluted EPS -$0.31 vs -$0.68.","Adjusted EBITDA net loss of $2.1M vs $3.0M; Truvaga sales surged 147% to $0.66M.","Cash and marketable securities $13.2M as of Sep 30, 2024, up from $10.6M at Dec 31, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.19,"consensus_revenue_estimate":null,"consensus_revenue_actual":18136000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207719,"accession_number":"0001193805-24-001098","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2024-09-06T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"ElectroCore CFO Brian Posner retiring Oct 4, 2024; Joshua Lev appointed CFO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Posner retiring effective Oct 4 for personal/family reasons; will provide consulting services for 12 months.","Joshua Lev, previously Chief Strategy Officer, appointed CFO effective Oct 4; base salary $415k, bonus target 40%.","Lev's severance period under Executive Severance Policy increased to 12 months with a severance multiple of 1.0.","Annual meeting results: directors Gandolfo and Theofilos elected; Marcum LLP ratified as auditor; compensation advisory votes passed.","Say-on-frequency vote favored 1 year; board determined to hold advisory vote on executive compensation annually."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207718,"accession_number":"0001213900-24-066120","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2024-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore Q2 net sales $6.1M (+73% YoY); net loss narrows to $2.7M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Seventh consecutive record quarterly revenue of $6.1M, up 73% YoY from $3.6M.","GAAP net loss of $2.7M vs $4.9M in Q2 2023; adjusted EBITDA loss of $1.9M vs $4.5M.","VA/DoD channel sales surged 120% to $4.6M; Truvaga up 97% to $572K.","Raised ~$9.0M via registered direct offering and concurrent private placements.","Launched Truvaga Plus app-enabled wellness product and next-gen TAC-STIM."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.9,"consensus_revenue_estimate":null,"consensus_revenue_actual":11582000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207717,"accession_number":"0001193805-24-000934","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2024-07-17T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Director Peter Cuneo reclassified to Class I; to become consultant after 2025 board term","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["F. Peter Cuneo resigned as Class III director and reappointed as Class I director, term expiring at 2025 Annual Meeting.","He will not stand for reelection at 2025 meeting and will then serve as consultant to CEO for one year.","Granted option to purchase 50,000 shares at $6.43/share, vesting monthly over 12 months.","Consulting fee: $500/hour or $3,000/day for days over 6 hours; expenses reimbursed.","Change is not due to any disagreement; Chairman role continues until 2025 meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":225192,"accession_number":"0001193805-24-000740","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2024-06-03T23:59:59+00:00","items":["1.01","3.02","7.01","9.01"],"status":"ready","headline":"electroCore raises $9.3M in equity/warrant offering with $5.645M from insiders","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds of ~$9.3M from registered direct & private placements; directors/officers invested $5.645M.","Securities: 225K registered pre-funded warrants + 112.5K warrants; private placement: 1,208,310 shares/pre-funded warrants + 604,150 warrants.","Combined effective price $6.4925/share+1/2 warrant; warrants exercise at $6.43, expire in 5 years.","Net proceeds used for sales/marketing, working capital, and general corporate purposes.","Offerings priced at market under Nasdaq rules; expected to close June 5, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":225191,"accession_number":"0001213900-24-040873","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2024-05-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore Q1 net sales up 96% to record $5.4M; GAAP loss narrows to $0.53/share","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Record Q1 net sales of $5.4M, up 96% from $2.8M in Q1 2023; driven by VA/DoD (+127%) and Truvaga (+162%).","GAAP net loss of $3.5M ($0.53 loss per share) vs $5.9M ($1.24 loss per share) in Q1 2023.","Adjusted EBITDA net loss improved to $3.1M from $5.1M in Q1 2023; gross margin held at 84%.","Cash, cash equivalents and restricted cash $8.1M vs $10.6M at Dec 31, 2023.","Launched DTC Truvaga Plus app-enabled wellness product during the quarter."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.53,"consensus_revenue_estimate":null,"consensus_revenue_actual":5443000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":244422,"accession_number":"0001213900-24-022169","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2024-03-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore reports FY2023 revenue $16.0M, up 87% YoY; Q4 revenue $5.2M, up 103%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Full year 2023 net sales of $16.0M, up 87% from $8.6M; Q4 net sales $5.2M, up 103% from $2.6M.","GAAP net loss improved to $18.8M from $22.2M; Adjusted EBITDA net loss narrowed to $15.4M from $19.0M.","VA/DoD channel drove growth: $9.6M revenue, +89% YoY; Truvaga and TAC-STIM combined $2.8M, up sharply.","Gross margin improved to 83% from 81%; net cash used in operations $14.7M vs $16.6M.","Cash and equivalents $10.6M at year-end vs $18.0M; raised $7.5M in July 2023 registered direct offering."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}